Bedside Snapshot
  • Cationic Protein: Positively charged protein that binds negatively charged heparin, forming inactive complex and reversing anticoagulant effect
  • Primary Uses: Reversal of unfractionated heparin (UFH) after procedures (cardiac surgery, PCI, dialysis) or in major bleeding; partial reversal of LMWH (e.g., enoxaparin)
  • Dosing: Based on amount of heparin given and time since administration; classic initial dosing ~1 mg protamine per 100 units UFH remaining in circulation
  • Administration: Must be given as slow IV infusion due to risk of severe hypotension, pulmonary vasoconstriction, and anaphylactoid reactions
  • High-Risk Populations: History of protamine exposure (including NPH insulin), fish allergy, men with prior vasectomy—monitor closely for reactions
  • LMWH Reversal: Only partially effective (~60-80% of anti-Xa activity neutralized)
Brand & Generic Names
  • Generic Name: Protamine sulfate
  • Brand Names: Protamine, generics
Medication Class

Heparin antagonist; cationic protein that neutralizes unfractionated heparin and partially reverses LMWH

Pharmacology

Mechanism of Action:

  • Protamine is a small, highly basic polypeptide that binds to heparin (strongly acidic/anionic glycosaminoglycan) through electrostatic interactions
  • The protamine-heparin complex is inactive and removed by reticuloendothelial system, reversing heparin's anticoagulant effect
  • For LMWH: Protamine neutralizes only part of anti-IIa and anti-Xa activity → reversal is incomplete (≈60-80% of anti-Xa)
  • Excess protamine: When given in excess relative to heparin, protamine itself can have weak anticoagulant effects and prolong clotting times

Pharmacokinetics (IV):

  • Onset: Anti-heparin effect is immediate after IV administration, with rapid normalization of ACT/aPTT if dosing appropriate
  • Duration: Approximately 2 hours, though effect may dissipate sooner if heparin continues to be released from tissue depots or ongoing infusion
  • Distribution: Confined largely to intravascular space; forms complexes with circulating heparin
  • Clearance: Protamine-heparin complexes cleared by reticuloendothelial system; excess free protamine may persist transiently and exert anticoagulant effects
Indications
  • UFH reversal post-procedure: After cardiopulmonary bypass and other surgical procedures
  • Emergency UFH reversal: Major bleeding (intracranial hemorrhage, massive GI bleed, bleeding at procedural sites)
  • Partial LMWH reversal: Enoxaparin in major bleeding or prior to emergent procedures
  • Interventional cardiology: Reversal of UFH used during PCI
  • Dialysis: Reversal of UFH from heparinized dialysis sessions
Dosing & Administration

Available Forms:

  • Injection: Typically 10 mg/mL solution (e.g., 50 mg in 5 mL vials) for IV administration
  • For safety, protamine is usually further diluted in 50-100 mL normal saline and infused slowly over at least 10 minutes

Protamine Sulfate Dosing (Adult):

Scenario Protamine Dose Route / Rate Notes
Immediate UFH reversal (within 30 min of IV bolus) 1 mg protamine per 100 units UFH IV over ≥10 min Calculate based on total heparin given in last 30-60 min; max single dose ~50 mg
UFH reversal 30-60 min after bolus 0.5-0.75 mg per 100 units UFH IV over ≥10 min Heparin partially cleared; reduce dose accordingly
UFH reversal >60 min after bolus ≈0.5 mg per 100 units UFH (or less) IV over ≥10 min Further adjust based on aPTT/ACT and clinical scenario
Continuous UFH infusion (therapeutic) 1-1.5 mg per 100 units UFH infused in last 2-3 h IV over ≥10 min Estimate total units based on infusion rate and time; consult pharmacy/heme
Enoxaparin (LMWH) within last 8 h 1 mg protamine per 1 mg enoxaparin IV over ≥10 min Neutralizes ~60-80% of anti-Xa; partial reversal only
Enoxaparin 8-12 h after dose 0.5 mg protamine per 1 mg enoxaparin IV over ≥10 min Reduced benefit as enoxaparin is partially cleared
Maximum recommended single dose 50 mg IV over ≥10 min Larger doses increase risk of severe reactions and paradoxical anticoagulation
Repeat dosing 0.5 mg per 100 units residual heparin IV over ≥10 min Guided by ACT/aPTT and ongoing bleeding
Slow Infusion Required: Rapid IV injection can cause severe hypotension, bradycardia, pulmonary vasoconstriction, and right heart failure. Must infuse slowly over ≥10 minutes.
Contraindications

Contraindications:

  • History of severe hypersensitivity or anaphylactic reaction to protamine

Major Precautions:

  • Hypersensitivity risk: Patients with fish allergy, prior protamine exposure (including NPH insulin), or prior vasectomy have higher risk of hypersensitivity reactions
  • Rapid infusion risks: Severe hypotension, bradycardia, pulmonary vasoconstriction, and right heart failure if given too quickly
  • Excess dosing: Protamine beyond what's needed to neutralize heparin can paradoxically prolong clotting times and impair hemostasis
  • Pulmonary hypertension: Use extreme caution in patients with pulmonary hypertension or significant right ventricular dysfunction
Adverse Effects

Common:

  • Flushing, warmth, feeling of chest discomfort
  • Mild hypotension, bradycardia
  • Nausea, vomiting

Serious:

  • Anaphylactic or anaphylactoid reactions (hypotension, bronchospasm, angioedema, shock)
  • Acute pulmonary hypertension and right ventricular failure
  • Severe hypotension and cardiovascular collapse
Monitoring

During and After Infusion:

  • Continuous ECG and blood pressure monitoring
  • Coagulation parameters (ACT, aPTT, anti-Xa where applicable) before and after reversal to gauge effectiveness
  • Clinical assessment of bleeding vs thrombosis, surgical site hemostasis, drain output
  • Signs of anaphylaxis or acute pulmonary hypertension: sudden hypoxemia, increased PA pressures (if monitored), bronchospasm, or shock
Clinical Pearls
Conservative Empiric Dosing: When time is limited, a conservative empiric dose (e.g., 25-50 mg) may be given while you refine heparin dose estimates and obtain coagulation labs.
Document Total Dose: Document the total amount of protamine given; overdosing can make re-heparinization difficult if needed later (e.g., return to OR or re-intervention).
Acute Reaction Protocol: An acute drop in BP or oxygen saturation during protamine infusion should trigger immediate suspicion for severe reaction—stop the infusion, support ABCs, and treat for anaphylaxis and/or pulmonary hypertension.
Not for DOACs: Protamine is not effective for reversing most direct oral anticoagulants or fondaparinux; use specific reversal agents or supportive care per protocol.
References
  • 1. Lexicomp. (2024). Protamine: Drug information. Wolters Kluwer.
  • 2. Farkas, J. (2022). Anticoagulant reversal. EMCrit Project / IBCC. https://emcrit.org/
Back to Medication Index
Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing and formatting this information. All content is reviewed for accuracy.